Pharmaceutical Industry Information Portal



GEROPHARM invests 2 billion roubles in medicinal product manufacture in Saint Petersburg

On June 16, GEROPHARM and the Government of Saint Petersburg at SPIEF-2023 signed a cooperation agreement to implement the investment project aimed at expanding the manufacture of medicinal products and increasing their export potential.

RNC Pharma: Top pharmacy chains in the Russian pharmaceutical retail market in Q1 2023

Market participants were significantly less active in early 2023 than during the rush demand in the spring of 2022. However, both inflation rates and stable household incomes now allow us to make optimistic industry growth forecasts, at least in the short term.

GEROPHARM will localize the production of 300 IU/mL insulin glargine in Kazakhstan

On June 8, at the Eurasia – Our Home exhibition, GEROPHARM and Karaganda Pharmaceutical Plant signed a long-term contract to localize the production of...

Dmitry Zaytsev has been named Chief Executive Officer of JSC “Pharmstandard”

JSC “Pharmstandard” informs about the change to the membership of the Company's management and the appointment of Dmitry Ivanovich Zaytsev as Chief Executive Officer. Potapov...

GMP-inspections of veterinary manufacturers in the first qarter of 2023

C 1 сентября этого года вступают в силу From September 1, 2023, amendments to Federal Law No. 61-FZ of 12.04.2010 "On the Circulation of...

The Russian Ministry of Health has authorized the first Russian originator for the treatment of multiple sclerosis

The Ministry of Health of the Russian Federation has authorized the first Russian originator for the treatment of multiple sclerosis developed by the scientists of...

Expert Articles